Site Location: Home > Client Services > Planning Services > Life Sciences

Business Planning for Life Sciences

Expantium provides business planning methodology, market insights and analysis to support decision-making in the pharmaceutical, biotechnology, diagnostic and medical device industries, focusing extensively on the corporate business development, finance and R&D functions.
Our services are used for growth and investment projects, fundraising, cost containment and resource allocation initiatives. Expantium provides cutting-edge planning and business evaluation methodology for your initiative including epidemiological market and patient flow modelling and sophisticated investment risk analysis.

Our expertise, which derives from delivering high-value programmes to large corporations, allows developing companies to benefit from the same power for planning and analysis as can be found within dedicated planning- and business evaluation departments of multinational corporations, but concretely focused to your situation and at less cost.

Our services focus on or combine approaches from the following areas:

Planning for capital raising initiatives
Strategic forecasting for growth and investment initiatives
Specialised financial modelling and risk analysis
Strategic R&D portfolio analysis and activity prioritisation

Select one of the links above to read more about our services that help engage planning for your growth initiative.


To find out more about Expantium's work in this solution area or how we can support the growth objective of your organisation, please contact lifesciences@expantium.com, call us or complete the contact form.